Related by context. Frequent words. (Click for all words.) 68 gastrointestinal stromal tumors 67 metastatic renal cell carcinoma 66 unresectable 66 squamous 66 metastatic breast 66 lymphoma CTCL 66 cell lung cancer 66 malignant pleural mesothelioma 65 HER2 positive metastatic breast 64 cutaneous T cell 63 Amrubicin 63 Nexavar ® 63 neoadjuvant therapy 62 Cell Lung Cancer 62 lung ovarian 62 Erlotinib 62 refractory multiple myeloma 62 FOLFIRI 62 Torisel 62 pertuzumab 62 metastatic colorectal cancer 62 Acute Myeloid Leukemia AML 61 metastatic NSCLC 61 Lenalidomide 61 NSCLC 61 relapsed multiple myeloma 61 dacarbazine 61 idiopathic pulmonary fibrosis IPF 61 temsirolimus 61 axitinib 61 Taxotere ® 61 cell carcinoma 61 chronic lymphocytic leukemia CLL 61 Hycamtin 61 liver metastases 60 B CLL 60 Jevtana 60 vandetanib 60 androgen independent 60 plus gemcitabine 60 imatinib mesylate 60 hepatocellular carcinoma HCC 60 plus dexamethasone 60 myelodysplastic syndromes MDS 60 glioblastoma multiforme GBM 60 Bevacizumab 60 gefitinib 60 refractory Hodgkin lymphoma 60 myelodysplastic syndrome MDS 60 grade glioma 60 nasopharyngeal cancer 60 fluorouracil 60 vinorelbine 60 Fludara 60 Alemtuzumab 60 tyrosine kinase inhibitors 59 pazopanib 59 plus prednisone 59 allogeneic stem cell 59 lung adenocarcinoma 59 TORISEL 59 relapsed refractory multiple myeloma 59 myelodysplastic syndromes 59 Avastin bevacizumab 59 Irinotecan 59 resistant ovarian cancer 59 dasatinib 59 colorectal breast 59 hormone refractory prostate cancer 59 BAY #-# 59 Vectibix 58 XELOX 58 metastatic pancreatic cancer 58 sunitinib 58 metastatic liver 58 Trastuzumab 58 sorafenib 58 soft tissue sarcomas 58 castration resistant prostate cancer 58 bladder cancers 58 metastatic colon cancer 58 EGFR inhibitors 58 aflibercept 58 Pirfenidone 58 Sorafenib 58 HER2 negative 58 advanced NSCLC 58 angiogenesis inhibitor 58 FOLFOX 58 neuroendocrine tumors 58 neoadjuvant chemotherapy 58 medullary thyroid cancer 58 nilotinib 58 invasive fungal infections 58 HER2 positive 58 eribulin 57 renal cell carcinoma 57 HGS ETR1 57 OPAXIO 57 Metastatic 57 Azedra